Global Diabetes Care Devices Market was valued at USD 50.1 Bn in 2021 & is predicted to grow at USD 79.2 Bn by 2028, at a CAGR of 6%, during period from 2022-2028.
The global Diabetes Care Devices Market accrued earnings worth approximately 50.1(USD Billion) in 2021 and is predicted to gain revenue of about 79.2(USD Billion) by 2028, is set to record a CAGR of nearly 6% over the period from 2022 to 2028. The study provides assessment and analysis of the Diabetes Care Devices Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Billion).
Diabetes care equipment is utilized for monitoring glucose levels of diabetics. Furthermore, these instruments enable insulin delivery into body of patient. In addition to this, diabetes is a chronic condition in which pancreas fails to produce enough amount of insulin for regulating sugar in human system. For the record, diabetes was tenth biggest mortality cause in 2019 as it was responsible for nearly 2 million deaths. Such incidences have prompted demand for diabetes care devices across globe.
Rise in cases of diabetics owing to inactive lifestyle along with swift industrialization will steer diabetes care devices market size. Furthermore, use of advanced blood glucose monitoring tools along with minimally invasive insulin delivery equipment for detecting diabetes has resulted in humungous demand for diabetes care devices in healthcare sector. Moreover, obesity issues and prominent surge in number of diabetes patients will fuel expansion of diabetes care devices market.
Furthermore, diabetes is assessed to be related to nearly 11.2% of global deaths across globe in coming years. Rising awareness pertaining to treatment of diabetes and supportive national health plans are set to expedite expansion of diabetes care devices industry. Moreover, diabetes is occurring at higher frequency in youth owing to irregular working hours and food habits. These, in turn, have created massive need of diabetes care devices in healthcare sector, thereby driving market progress.
Report Scope:
North American Diabetes Care Devices Market To Record Astounding Growth By 2028
Growth of diabetes care devices market in North America over forecasting timeline is subject to rise in number of diabetics in North America. For the record, recently there are over 30 million diabetics in North America and the number is projected to surge to about 34 million in 2026. Furthermore, supportive reimbursement guidelines along with strong presence of healthcare infrastructure in countries such as the U.S. and Canada will proliferate regional market surge.
Some of the major players have strongly leveraged size of diabetes care devices market across globe and will retain their market domination even in next few years. We have compiled their profiles in our report and they are Terumo Corporation, Acon Laboratories, Inc., Abbott Laboratories, Dexcom, Inc., Novo Nordisk A/S, Johnson & Johnson, Bayer AG, Merck & Co., Inc., The Ypsomed Group, Roche Diagnostics Ltd., Becton, Dickinson and Company, Medtronic plc, ARKRAY, Inc., and Sanofi S.A.
The global Diabetes Care Devices Market is segmented as follows:
By Glucose Monitoring Device
By Insulin Delivery Device
By Region
FrequentlyAsked Questions
Rise in cases of diabetics owing to inactive lifestyle along with swift industrialization will steer diabetes care devices market size.
According to Zion market research report, the global Diabetes Care Devices Market accrued earnings worth approximately 50.1(USD Billion) in 2021 and is predicted to gain revenue of about 79.2(USD Billion) by 2028, is set to record a CAGR of nearly 6% over the period from 2022 to 2028.
North America will contribute sizably towards the global market revenue over the projected timeline. A massive increase in Diabetes Care Devices Market size in sub-continent over 2022-2028 can be due to rise in number of diabetics in North America.
The key industry participants leveraging business space include Terumo Corporation, Acon Laboratories, Inc., Abbott Laboratories, Dexcom, Inc., Novo Nordisk A/S, Johnson & Johnson, Bayer AG, Merck & Co., Inc., The Ypsomed Group, Roche Diagnostics Ltd., Becton, Dickinson and Company, Medtronic plc, ARKRAY, Inc., and Sanofi S.A.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed